by Editor | Dec 7, 2020 | Diabetes Therapy, Procyon-Technologies News
Procyon Technologies LLC today announced that it has entered into an exclusive research collaboration and license agreement with Novo Nordisk A/S to develop an implantable cell encapsulation device to be used in Novo Nordisk’s development of a novel therapy for Type 1 diabetes.
by Editor | Oct 4, 2019 | Diabetes Therapy, Procyon-Technologies News
Dr. Kowalski, JDFR president and CEO, recognized research being done by Dr. Klearchos Papas and Dr. Robert Johnson. Drs. Papas and Johnson are with the University of Arizona in Tucson, and are developing groundbreaking cell therapies to cure T1D through two projects:...
by Editor | Oct 2, 2019 | Diabetes Therapy, Procyon-Technologies News
Unfortunately insulin shots, pens and pumps fail to perfectly manage blood sugar in many children, which may lead to long-term complications. For the last two decades, Dr. Papas has been working on a solution to this problem. In collaboration with other scientists...
by Editor | Oct 2, 2019 | Diabetes Therapy, Procyon-Technologies News
On April 2, 2019, Insulin Nation published an article about teams from the Universities of Arizona and Minnesota collaborating and on Klearchos Papas, PhD about his oxygen generator-based islet ‘tea bag’ transplant device. See Oxygen Critical to Practical Islet...
by Editor | Oct 1, 2019 | Diabetes Therapy, Procyon-Technologies News
Dr. Papas and his team developed a technology that allows insulin producing islet cells to be surgically implanted in the body
